Brain prostaglandin formation is increased by α-synuclein gene-ablation during global ischemia

Neuroscience Letters

Volumn 432, Issue 3, 2008, Pages 243-247

  Golovko, Mikhail Y ^a   Murphy, Eric J ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Acyl CoA synthetase; Alpha synuclein; Arachidonic acid; Brain fatty acids; Neuroinflammation; Prostaglandin

Indexed keywords

ALPHA SYNUCLEIN; ARACHIDONIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; PHOSPHOLIPASE D; PHOSPHOLIPID; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; CONTROLLED STUDY; ENCEPHALITIS; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION; ISCHEMIA; MALE; MICE; MICE, KNOCKOUT; PROSTAGLANDINS; TANDEM MASS SPECTROMETRY;

EID: 39149105267     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.12.031     Document Type: Article

References (54)

1. Ahn B.H., Rhim H., Kim S.Y., Sung Y.-M., Lee M.-Y., Choi J.-Y., Wolozin B., Chang J.-S., Lee Y.H., Kwon T.K., Chung K.C., Yoon S.-H., Hahn S.J., Kim M.-S., Jo Y.-H., and Min D.S. α-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. J. Biol. Chem. 277 14 (2002) 12334-12342
2. Anton R.F., Wallis C., and Randall C.L. In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins 26 3 (1983) 421-429
3. Austin S.A., Floden A.M., Murphy E.J., and Combs C.K. α-Synuclein expression modulates microglial activation phenotype. J. Neurosci. 26 4 (2006) 10558-10563
4. 2 by protein kinase C in P388D1 macrophages. Biochem. J. 321 (1997) 805-809
5. Bazan N.G. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta 218 (1970) 1-10
6. Bazan N.G., Aveldaño de Caldironi M.I., and Rodríguez de Turco E.B. Rapid release of free arachidonic acid in the central nervous system due to stimulation. Prog. Lipid Res. 20 (1981) 523-529
7. Bosisio E., Galli C., Galli G., Nicosia S., Spagnuolo C., and Tosi L. Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex cerebellum. Prostaglandins 11 5 (1976) 773-781
8. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.C., Orrison B., Chen A., Ellis C.E., Paylor R., Lu B., and Nussbaum R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking α-synuclein. J. Neurosci. 22 20 (2002) 8797-8807
9. Castagnet P.I., Golovko M.Y., Barceló-Coblijn G., Nussbaum R.L., and Murphy E.J. Fatty acid incorporation is decreased in astrocytes cultured from α-synuclein gene-ablated mice. J. Neurochem. 94 3 (2005) 839-849
10. Chen J., Weinstein P.R., and Graham S.H. Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cycloxygenase-lipoxygenase inhibitor BW755C. J. Neurosurg. 83 1 (1995) 99-104
11. De Valck D., Beyaert R., Van Roy F., and Fiers W. Tumor necrosis factor cytotoxicity is associated with phospholipase D activation. Eur. J. Biochem. 212 2 (1993) 491-497
12. Deutsch J., Rapoport S.I., and Purdon A.D. Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22 7 (1997) 759-765
13. C. Galli, G. Racagni, Use of microwave techniques to inactivate brain enzymes rapidly, in: W.E.M. Lands, W.L. Smith (Eds.), Prostaglandins and Arachidonate Metabolites, Methods in Enzymology, vol. 86 Academic Press, New York, (1982) pp. 635-642.
14. Golovko M.Y., Færgeman N.J., Cole N.B., Castagnet P.I., Nussbaum R.L., and Murphy E.J. α-Synuclein gene-deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of α-synuclein palmitate binding. Biochemistry 44 23 (2005) 8251-8259
15. Golovko M.Y., Rosenberger T.A., Færgeman N.J., Feddersen S., Cole N.B., Pribill I., Berger J., Nussbaum R.L., and Murphy E.J. Acyl-CoA synthetase activity links wild-type but not mutant α-synuclein to brain arachidonate metabolism. Biochemistry 45 (2006) 6956-6966
16. Golovko M.Y., Rosenberger T.A., Feddersen S., Færgeman N.J., and Murphy E.J. α-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J. Neurochem. 101 (2007) 201-211
17. Hu X., Rea H.C., Wiktorowicz J.E., and Perez-Polo J.R. Proteomic analysis of hyppoxia/ischemia-induced alteration of cortical development and dopamine neurotransmission in neonatal rat. J. Proteome Res. 5 2396 (2006) 2404
18. Ikeda M., Yoshida S., Busto R., Santiso M., and Ginsberg M.D. Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia. J. Neurochem. 47 (1986) 123-132
19. Iseki E., Marui W., Kosaka K., Akiyama H., Ueda K., and Iwatsubo T. Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci. Lett. 258 2 (1998) 81-84
20. Ishimaru H., Uéda K., Takahashi A., and Maruyama Y. Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus. Brain Res. 788 (1998) 311-314
21. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 2 (1995) 467-475
22. Jakes R., Spillantini M.G., and Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett. 345 (1994) 27-32
23. Jenco J.M., Rawlingson A., Daniels B., and Morris A.J. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry 37 14 (1998) 4901-4909
24. Jo E., McLaurin J., Yip C.M., George-Hyslop P.St., and Fraser P.E. α-Synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275 (2000) 34328-34334
25. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber S., Kosel S., Przuntek H., Epplen J.T., Schols L., and Reiss O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
26. Lin T.N., Liu T.H., Xu J., Hsu C.Y., and Sun G.Y. Brain polyphosphoinositide metabolism during focal ischemia in rat cortex. Stroke 22 (1991) 495-498
27. Lippa C.F., Schmidt M.L., Lee V.M., and Trojanowski J.Q. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann. Neurol. 45 3 (1999) 353-357
28. Maroteaux L., Campanelli J.T., Scheller R.H., and Synuclein:. A neuron-specific protein localized in the nucleus and presynaptic nerve terminal. J. Neurosci. 8 8 (1988) 2804-2815
29. Masoodi M., and Nicolaou A. Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectromet. 20 3023 (2006) 3029
30. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Dis. 10 (2004) S3-S7
31. McLean P.J., Ribich S., and Hyman B.T. Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations. J. Neural Transm. Suppl. 58 (2000) 53-63
32. Meats J.E., Steele L., and Bowen J.G. Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. Agents Actions 39 (1993) C14-C16
33. Mori F., Tanji K., Yoshimoto M., Takahashi H., and Wakabayashi K. Demonstration of α-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinkinase K and formic acid pretreatment. Exp. Neurol. 176 (2002) 98-104
34. 2+ during combined oxygen-glucose deprivation in primary astrocyte cell cultures. J. Neurosci. Res. 42 (1995) 109-116
35. Nagatsu T., and Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharmaceut. Design 11 8 (2005) 999-1016
36. Papadopoulos D., Ewans L., Pham-Dinh D., Knott J., and Reynolds R. Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease. Mol. Cell. Neurosci. 31 (2006) 597-612
37. Payton J.E., Perrin R.J., Woods W.S., and George J.M. Structural determinants of PLD2 inhibition by alpha-synuclein. J. Mol. Biol. 337 4 (2004) 1001-1009
38. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., DiIorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
39. Powell W.S. Precolumn extraction and reversed-phase high-pressure liquid chromatography of prostaglandins and leukotrienes. Anal. Biochem. 164 1 (1987) 117-131
40. Powner D.J., Payne R.M., Pettitt T.R., Guidici M.L., Irvine R.F., and Wakelam M.J. Phospholipase D2 stimulates integrin-mediated adhesion via phosphatidylinositol 4-phosphate 5-kinase l Γ b. J. Cell Sci. 118 Pt 13 (2005) 2975-2986
41. Rabin O., Deutsch J., Grange E., Pettigrew K.D., Chang M.C.J., Rapoport S.I., and Purdon A.D. Changes in cerebral acyl-CoA concentrations following ischemia-reperfusion in awake gerbils. J. Neurochem. 68 (1997) 2111-2118
42. Rabin O., Chang M.C.J., Grange E., Bell J., Rapoport S.I., Deutsch J., and Purdon A.D. Selective acceleration of arachidonic acid reincorporation into brain membrane phospholipid following transient ischemia in awake gerbil. J. Neurochem. 70 (1998) 325-334
43. Richter-Landsberg C., Gorath M., Trojanowski J.Q., and Lee V.M. Alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J. Neurosci. Res. 62 (2000) 9-14
44. Serrander L., Fallman M., and Stendahl O. Activation of phospholipase D is an early event in integrin-mediated signalling leading to phagocytosis in human neutrophils. Inflammation 20 4 (1996) 439-450
45. Shibayama-Imazu T., Okahashi I., Omata K., Nakajo S., Ochiai H., Nakai Y., Hama T., Nakamura Y., and Nakaya K. Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res. 622 1-2 (1993) 17-25
46. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. α-Synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
47. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., and Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251 3 (1998) 205-208
48. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Sisk A., and Masliah E. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab. Invest. 78 9 (1998) 1169-1177
49. Teismann P., and Schulz J.B. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 318 (2004) 149-161
50. Trojanowski J.Q., Goedert M., Iwatsubo T., and Lee V.M. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Different. 5 10 (1998) 832-837
51. 2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostagl. Leukotr. Essen. Fatty Acids 69 (2003) 437-448
52. Yoon D.-K., Hwang I.K., Yoo K.-Y., Lee Y.-B., Lee J.-J., Kim J.-H., Kang T.-C., Lee B.-H., Sohn H.-S., and Won M.H. Comparison of α-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase. Neurosci. Res. 55 (2006) 434-441
53. Yoshida S., Ideda M., Busto R., Santiso M., Martinez E., and Ginsberg M.D. Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J. Neurochem. 47 (1986) 744-757
54. Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., del Ser T., Muñoz D.G., and de Yebenes J.G. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy Body dementia. Ann. Neurol. 55 (2004) 164-173